CD8A and colorectal carcinoma: Similarly, in the NICHE study, where patients with dMMR– or pMMR–CRC received ipilimumab and nivolumab before surgery, dMMR patients showed a significantly higher TCR clonality in CD8+ T cells than the pMMR patients at the baseline.